2.56

9.40% 0.22

After Hours: 2.56

Caribou Biosciences Inc (CRBU)

Overview News Price History Option Chain Financials Why CRBU Down? Discussions Forecast

Caribou Biosciences Inc stock is traded at $2.56, with a volume of 2.95M. It is up +9.40% in the last 24 hours and up +36.90% over the past month. Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.

Previous Close:

$2.34

Open:

$2.3

24h Volume:

2.95M

Relative Volume:

2.99

Market Cap:

$229.07M

Revenue:

$34.48M

Net Income/Loss:

$-102.07M

P/E Ratio:

-1.4066

EPS:

-1.82

Net Cash Flow:

$-104.90M

1W Performance:

+32.64%

1M Performance:

+36.90%

6M Performance:

-32.10%

1Y Performance:

-38.76%

1-Day Range:

$2.295

$2.58

1-Week Range:

$1.865

$2.58

52-Week Range:

$1.50

$8.33

Caribou Biosciences Inc Stock (CRBU) Company Profile

Name

Caribou Biosciences Inc

Sector

Healthcare (1182)

Industry

Biotechnology (671)

Phone

510-982-6030

Address

2929 7TH STREET, SUITE 105, BERKELEY

Employee

137

Twitter

Next Earnings Date

Latest SEC Filings

CRBU's Discussions on Twitter

Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-11-23	Initiated	Truist	Buy
Feb-18-22	Initiated	RBC Capital Mkts	Outperform
Dec-01-21	Initiated	Oppenheimer	Outperform
Nov-30-21	Initiated	H.C. Wainwright	Buy
Nov-15-21	Upgrade	Citigroup	Neutral → Buy
Aug-17-21	Initiated	BofA Securities	Buy
Aug-17-21	Initiated	Citigroup	Neutral
Aug-17-21	Initiated	SVB Leerink	Outperform

View All

Caribou Biosciences Inc Stock (CRBU) Latest News

06:10 AM

Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Shares Bounce 25% But Its Business Still Trails The Industry - Simply Wall St

06:10 AM

02:12 AM

Vanguard Group Inc's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

02:12 AM

Oct 31, 2024

Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock? - Insider Monkey

Oct 31, 2024

Oct 30, 2024

10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey

Oct 30, 2024

Oct 22, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by Exchange Traded Concepts LLC - Defense World

Oct 22, 2024

Oct 17, 2024

STATE STREET CORP's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

Oct 17, 2024

Following a 49% decline over last year, recent gains may please Caribou Biosciences, Inc. (NASDAQ:CRBU) institutional owners - Simply Wall St

Oct 17, 2024

Oct 16, 2024

Its Stock Has Paid Off Big Time For Caribou Biosciences Inc - SETE News

Oct 16, 2024

Oct 15, 2024

How to interpret Caribou Biosciences Inc (CRBU)’s stock chart patterns - US Post News

Oct 15, 2024

Oct 14, 2024

Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 5.56 Increase, Closing at 1.90 - The Dwinnex

Oct 14, 2024

Oct 10, 2024

Dimensional Fund Advisors LP Has $4.30 Million Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat

Oct 10, 2024

Oct 09, 2024

A better buy-in window may exist right now for Caribou Biosciences Inc (CRBU) - SETE News

Oct 09, 2024

Oct 08, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Purchased by Green Alpha Advisors LLC - Defense World

Oct 08, 2024